Target intelligence / Profile preview

KIAA1671 antisense RNA 1 (KIAA1671-AS1)

Target
KIAA1671-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-coding RNA
01

Overview

KIAA1671 antisense RNA 1 (KIAA1671-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 22 (chr22:25102417-25112716, hg38)[1][3]. It is classified as an antisense RNA—RNA molecules transcribed from the DNA strand opposite to the coding (sense) gene and is not translated into protein[7]. Like other naturally occurring antisense RNAs, KIAA1671-AS1 is implicated in the regulation of gene expression through various molecular mechanisms, which may include interaction with complementary messenger RNAs, modulation of chromatin structure, or influence on transcriptional processes[2][5]. The specific functional roles of KIAA1671-AS1 remain incompletely characterized, but diseases associated with dysregulation of this RNA include retinitis pigmentosa[3]. There are no known direct drug interactions, established uses as a biomarker, or documented safety concerns linked to targeting this RNA. Its principal molecular classification is as a long non-coding antisense RNA rather than as a protein-coding target such as a receptor, enzyme, or transporter[3][7].

Other names
CTA-221G9.11KIAA1671-AS1
02

Biological functions

Regulation of gene expressionEpigenetic regulation (such as promoter/enhancer interaction, chromatin modification)Possible involvement in RNA-mediated silencing
03

Disease associations

Retinitis pigmentosa

Beyond the preview

Go deeper on KIAA1671 antisense RNA 1 (KIAA1671-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KIAA1671 antisense RNA 1 (KIAA1671-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call